Rapid combinatorial access to a library of 1,5-disubstituted-3-indole-N- alkylacetamides as CB2 receptor ligands

Journal of Combinatorial Chemistry

Volumn 11, Issue 5, 2009, Pages 795-798

  Pasquini, Serena ^a   Mugnaini, Claudia ^a   Brizzi, Antonella ^a   Ligresti, Alessia ^b   Di Marzo, Vincenzo ^b   Ghiron, Chiara ^c   Corelli, Federico ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b CNR   (Italy)

^c Siena Biotech SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAMIDE DERIVATIVE; CANNABINOID 2 RECEPTOR; LIGAND;

ARTICLE; CHEMISTRY; COMBINATORIAL CHEMISTRY; METABOLISM;

ACETAMIDES; COMBINATORIAL CHEMISTRY TECHNIQUES; LIGANDS; RECEPTOR, CANNABINOID, CB2;

EID: 70349335584     PISSN: 15204766     EISSN: None     Source Type: Journal    
DOI: 10.1021/cc9000955     Document Type: Article

References (21)

1. Humphrey, G. R.; Kuethe, J. T. Chem. Rev. 2006, 106, 2875-2911.
2. (a) Basavarajappa, B. S.; Nixon, R. A.; Arancio, O. MiniRev. Med. Chem. 2009, 9, 448-462.
3. (b) Graham, E. S.; Ashton, J. C.; Glass, M. Front. Biosci. 2009, 14, 966-1957
4. (c) Janero, D. R.; Makriyannis, A. Expert Opin. Emerg. Drugs 2009, 14, 43-65.
5. (d) Pertwee, R. G. Br. J. Pharmacol. 2009, 156, 397-411.
6. (a) Lange, J. H. M.; Kruse, C. G. Drug Discovery Today 2005, 10, 693-702.
7. (b) Barth, F. Annu. Rep. Med. Chem. 2005, 40, 103-118.
8. (c) Muccioli, G. G.; Lambert, D. M. Exp. Op. Ther. Pat. 2006, 16, 1405-1423.
9. Tucci, S. A.; Halford, J. C. G.; Harrold, J. A.; Kirkham, T. C. Curr. Med. Chem. 2006, 13, 2669-2680.
10. (a) Rinaldi-Carmona, M.; Barth, F.; Héaulme, M.; Shire, D.; Calandra, B.; Congy, C.; Martinez, S.; Maruani, J.; Néliat, G.; Caput, D.; Ferrara, P.; Soubrié, P.; Brelière, J. C.; Le Fur, G. FEBS Lett. 1994, 350, 240-244.
11. (b) Sorbera, L. A.; Castaner, J.; Silvestre, J. S. Drugs Future 2005, 30, 128-137.
12. Marketing authorization of European Medicines Agency (EMEA) valid throughout the European Union: 19 June 2006. European Public Assessment Report (EPAR). Acomplia. Protocol EMEA/H/C/666.
13. Mackie, K.; Ross, R. A. Br. J. Pharmacol. 2008, 153, 177-178, and references cited therein.
14. Manera, C.; Tuccinardi, T.; Martinelli, A. Mini Rev. Med. Chem. 2008, 8, 370-387.
15. Silvestri, R.; Caseio, M. G.; La Regina, G.; Piscitelli, F.; Lavecchia, A.; Brizzi, A.; Pasquini, S.; Botta, M.; Novellino, E.; Di Marzo, V.; Corelli, F. J. Med. Chem. 2008, 51, 1560-1576.
16. Pasquini, S.; Botta, L.; Semeraro, T.; Mugnaini, C.; Ligresti, A.; Palazzo, E.; Maione, S.; Di Marzo, V.; Corelli, F. J. Med. Chem. 2008, 51, 5075-5084.
17. Brizzi, A.; Brizzi, V.; Caseio, M. G.; Corelli, F.; Guida, F.; Ligresti, A.; Maione, S.; Martinelli, A.; Pasquini, S.; Tuccinardi, T.; Di Marzo, V. J. Med. Chem. 2009, 52, 2506-2514.
18. Spadoni, G.; Bedini, A.; Guidi, T.; Tarzia, G.; Lucini, V.; Pannacci, M.; Fraschini, F. ChemMedChem 2006, 1, 1099-1105.
19. 5-Hydroxyindole (5a) was purchased from Sigma-Aldrich.
20. Compounds 5b and 5c were prepared starting from 5-hydroxyindole-3-acetic acid according to the procedure described in Supporting Information.
21. Stoll, A.; Troxler, F.; Peyer, J.; Hofmann, A. Helv. Chim. Acta 1955, 38, 1452-1472.